Impact of Mandatory Public Reporting of Central Line-Associated Bloodstream Infections on Blood Culture and Antibiotic Utilization in Pediatric and Neonatal Intensive Care Units

Infection Control and Hospital Epidemiology

Volumn 36, Issue 8, 2015, Pages 878-885

  Flett, Kelly B ^a,b   Ozonoff, Al ^a,b   Graham, Dionne A ^a,b   Sandora, Thomas J ^a,b   Priebe, Gregory P ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; DRUG UTILIZATION; EPIDEMIOLOGY; HUMAN; INFANT; MANDATORY REPORTING; MEDICAL INFORMATION SYSTEM; NEONATAL INTENSIVE CARE UNIT; PEDIATRIC HOSPITAL; PEDIATRIC INTENSIVE CARE UNIT; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; TREND STUDY; UMBILICAL VEIN CATHETER; ADVERSE EFFECTS; BACTEREMIA; BACTERIAL COUNT; BLOOD; CATHETER-RELATED INFECTIONS; CROSS INFECTION; MICROBIOLOGY; STATISTICS AND NUMERICAL DATA; UNITED STATES; UTILIZATION;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BLOOD; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERS; COLONY COUNT, MICROBIAL; CROSS INFECTION; HUMANS; INFANT; INTENSIVE CARE UNITS, NEONATAL; INTERRUPTED TIME SERIES ANALYSIS; MANDATORY REPORTING; UNITED STATES;

EID: 84988884563     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2015.100     Document Type: Article

References (35)

1. Magill SS, Edwards JR, Bamberg W, et al. Multistate pointprevalence survey of health care-associated infections. N Engl J Med 2014;370:1198-1208.
2. Fung CH, Lim Y-W, Mattke S, Damberg C, Shekelle PG. Systematic review: the evidence that publishing patient care performance data improves quality of care. Ann Intern Med 2008;148: 111-123.
3. Muller MP, Detsky AS. Public reporting of hospital hand hygiene compliance-helpful or harmful JAMA 2010;304:1116-1117.
4. Klevens RM, Edwards JR, Richards CL, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007;122:160-166.
5. Pines JM, Isserman JA, Hinfey PB. The measurement of time to first antibiotic dose for pneumonia in the emergency department: a white paper and position statement prepared for the American Academy of Emergency Medicine. J Emerg Med 2009;37:335-340.
6. Joynt KE, Blumenthal DM, Orav EJ, Resnic FS, Jha AK. Association of public reporting for percutaneous coronary intervention with utilization and outcomes among Medicare beneficiaries with acute myocardial infarction. JAMA 2012;308:1460-1468.
7. Backman LA, Melchreit R, Rodriguez R. Validation of the surveillance and reporting of central line-associated bloodstream infection data to a state health department. Am J Infect Control 2010;38:832-838.
8. Uchida M, Stone PW, Conway LJ, Pogorzelska M, Larson EL, Raveis VH. Exploring infection prevention: policy implications from a qualitative study. Policy Polit Nurs Pract 2011;12:82-89.
9. Polk RE, Hohmann SF, Medvedev S, Ibrahim O. Benchmarking risk-adjusted adult antibacterial drug use in 70 US academic medical center hospitals. Clin Infect Dis 2011;53:1100-1110.
10. Gerber JS, Newland JG, Coffin SE, et al. Variability in antibiotic use at children's hospitals. Pediatrics 2010;126:1067-1073.
11. Claridge JA, Pang P, Leukhardt WH, Golob JF, Carter JW, Fadlalla AM. Critical analysis of empiric antibiotic utilization: establishing benchmarks. Surg Infect (Larchmt) 2010;11:125-131.
12. Wylie MC, Graham DA, Potter-Bynoe G, et al. Risk factors for central line-associated bloodstream infection in pediatric intensive care units. Infect Control Hosp Epidemiol 2010;31:1049-1056.
13. Odetola FO, Moler FW, Dechert RE, VanDerElzen K, Chenoweth C. Nosocomial catheter-related bloodstream infections in a pediatric intensive care unit: risk and rates associated with various intravascular technologies. Pediatr Crit Care Med 2003;4:432-436.
14. Elward AM, Fraser VJ. Risk factors for nosocomial primary bloodstream infection in pediatric intensive care unit patients: a 2-year prospective cohort study. Infect Control Hosp Epidemiol 2006;27:553-560.
15. Yogaraj JS, Elward AM, Fraser VJ. Rate, risk factors, and outcomes of nosocomial primary bloodstream infection in pediatric intensive care unit patients. Pediatrics 2002;110:481-485.
16. Feudtner C, Hays RM, Haynes G, Geyer JR, Neff JM, Koepsell TD. Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services. Pediatrics 2001;107:E99.
17. Roque P, Oliver B, Anderson L, et al. Inpatient utilization of blood cultures drawn in an urban ED. Am J Emerg Med 2012;30: 110-114.
18. Sturmann KM, Bopp J, Molinari D, Akhtar S, Murphy J. Blood cultures in adult patients released from an urban emergency department: a 15-month experience. Acad Emerg Med 1996;3:768-775.
19. Laupland KB, Church DL, Gregson DB. Blood cultures in ambulatory outpatients. BMC Infect Dis 2005;5:35.
20. Darby JM, Linden P, Pasculle W, Saul M. Utilization and diagnostic yield of blood cultures in a surgical intensive care unit. Crit Care Med 1997;25:989-994.
21. Hillier R, Everett B. Evaluating culture practices used to identify infection in patients with brain injury. Crit Care Nurs Q 2012;35:228-233.
22. Kiragu AW, Zier J, Cornfield DN. Utility of blood cultures in postoperative pediatric intensive care unit patients. Pediatr Crit Care Med 2009;10:364-368.
23. Gross PA, Van Antwerpen CL, Hess WA, Reilly KA. Use and abuse of blood cultures: program to limit use. Am J Infect Control 1988;16:114-117.
24. Madsen KM, Schønheyder HC, Kristensen B, Sørensen HT. Secular trends in incidence and mortality of bacteraemia in a Danish county 1981-1994. APMIS 1999;107:346-352.
25. Hadziyannis AS, Stephanou I, Dimarogona K, et al. Blood culture results during the period 1995-2002 in a Greek tertiary care hospital. Clin Microbiol Infect 2004;10:667-670.
26. McCaig LF, McDonald LC, Cohen AL, Kuehnert MJ. Increasing blood culture use at US hospital emergency department visits, 2001 to 2004. Ann Emerg Med 2007;50:42-48.e2.
27. Grohskopf LA, Huskins WC, Sinkowitz-Cochran RL, et al. Use of antimicrobial agents in United States neonatal and pediatric intensive care patients. Pediatr Infect Dis J 2005;24:766-773.
28. Zingg W, Pfister R, Posfay-Barbe KM, Huttner B, Touveneau S, Pittet D. Secular trends in antibiotic use among neonates: 2001-2008. Pediatr Infect Dis J 2011;30:365-370.
29. Pakyz AL, Gurgle HE, Ibrahim OM, Oinonen MJ, Polk RE. Trends in antibacterial use in hospitalized pediatric patients in United States academic health centers. Infect Control Hosp Epidemiol 2009;30:600-603.
30. Meddings JA, Reichert H, Rogers MAM, Saint S, Stephansky J, McMahon LF. Effect of nonpayment for hospital-acquired, catheter-associated urinary tract infection: a statewide analysis. Ann Intern Med 2012;157:305-312.
31. Morgan DJ, Meddings J, Saint S, et al. Does nonpayment for hospital-acquired catheter-associated urinary tract infections lead to overtesting and increased antimicrobial prescribing Clin Infect Dis 2012;55:923-929.
32. Lee GM, Kleinman K, Soumerai SB, et al. Effect of nonpayment for preventable infections in U.S. hospitals. N Engl J Med 2012;367:1428-1437.
33. Cox E, Flaspohler T, Jennings A, et al. Attempts to change culture in a line-obsessed pediatric world: the Riley Heart Center line initiative. Am J Infect Control 2011;39:690-692.
34. Blanchard AC, Fortin E, Rocher I, et al. Central line-associated bloodstream infection in neonatal intensive care units. Infect Control Hosp Epidemiol 2013;34:1167-1173.
35. Wirtschafter DD, Padilla G, Suh O, Wan K, Trupp D, Fayard EES. Antibiotic use for presumed neonatally acquired infections far exceeds that for central line-associated blood stream infections: an exploratory critique. J Perinatol 2011;31:514-518.